₹785.35
+0.01% today
· 30d -6.24%
as of 2026-09-04
Price · Daily Candles
“Aster DM Healthcare: DIIs double down as FIIs trim exposure amid strong quarterly profit surge.”
Aster DM Healthcare's Q4 2026 results show exceptional net profit growth of 79.54% YoY, reaching ₹154 Cr, despite annual profit declining 92.1% YoY to ₹427 Cr. DIIs increased their stake by 1.45% QoQ to 27.57%, while FIIs pared holdings by 1.28% to 17.18%. The stock trades at a TTM P/E of 118.01, significantly above its direct peer median.
BULL CASE
+Q4 2026 net profit surged by 79.54% YoY to ₹154 Cr, driven by an 18.2% YoY revenue increase to ₹1182 Cr.
+Operating profit for Q4 2026 grew by 20.34% YoY, reaching ₹269 Cr, with OPM improving by 0.41%.
+ML predictions indicate strong sales growth, with recent 2-year sales rank at 0.813 and stable 7-year sales rank at 0.724.
+DII ownership increased by 1.45 percentage points QoQ, now holding 27.57% of the company's shares.
+The stock is trading only 2.4% off its 52-week high of ₹776.55, reflecting positive market momentum with a 1-year return of 30.82%.
BEAR CASE
−Annual net profit for FY26 plummeted by 92.1% YoY to ₹427 Cr compared to the previous fiscal year.
−The TTM PE ratio stands at 118.01, notably higher than the sector median among closest peers like NH (47.68) and Medanta (59.34).
−FIIs reduced their stake by 1.28 percentage points QoQ, bringing their total holding to 17.18%.
−ML models predict weak free cash flow growth across various time horizons, with rolling 4-year fcf rank at 0.005.
−The intrinsic value model is flagged as unreliable due to predicted severe FCF compression (e.g., h1=-29.6% of mktcap).
⟳ What Changed
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹1311 Cr
+21.6% YoY
NET PROFIT
₹29 Cr
-68.7% YoY
OPM
22.36%
+0.71pp YoY
EPS
₹0.31
PE 118.01
Intrinsic value · DCF: N/A — ML model predicts severe Δ FCF compression (h1=-27.6%, h2=-19.5%, h3=-22.2% of mktcap), driving projected FCF negative by year 3 despite healthy current FCF. Treating as forecast outlier rather than reporting a misleading ₹0 valuation. Use the Strategy Fit and ML sections instead.
◇ Sector Position
Aster DM Healthcare's TTM P/E of 118.01 is higher than sector peers like NH (47.68) and Medanta (59.34), while its ROCE of 11.0% is below the peer average.
PEERPEROCE %
ASTERDM118.0111.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
60
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
90
Valuation
STRETCHED
5
Growth
STEADY
51
Profitability
DECENT
68
Technicals
NEUTRAL
55
Risk
LOW
90
Key Stats
TTM PE
118.01
P/B
8.53
52W HIGH
₹891.3
OFF HIGH
-11.89%
DIV YIELD
0.54%
MKT CAP
₹40579 Cr
◉ Active Signals
MACDNeutral0.195
RSI(14)Neutral49.54
Street Consensus
11 analysts₹795.27
mean target
Low ₹743.0Now ₹785.35High ₹890.0
⧉ Strategy Fit 🔒